http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I687431-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c539db959cc0106cab1662303f94fce |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6558 |
| filingDate | 2015-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d99919afbf3624b6c93ad878e2c3bcaf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_710a1184ed2afd44c6057b76c0e7e711 |
| publicationDate | 2020-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-I687431-B |
| titleOfInvention | Prodrugs for the treatment of cancer |
| abstract | The invention provides compounds of the formula: n n R 1 is OR 11 , or NR 5 R 5' ; R 2 is H or F; R 5 is H, C 1 -C 6 alkyl, OH, C(=O)R 6 , O(C=O)R 6 or O(C=O)OR 6 ; R 5' is H or C 1 -C 6 alkyl; R 6 is C 1 -C 6 alkyl or C 3 -C 7 cycloalkyl; R 13 is H, phenyl, pyridyl, benzyl, indolyl or naphthyl wherein the phenyl, pyridyl, benzyl, indolyl and naphthyl is optionally substituted with 1, 2 or 3 R 22 ; and the other variables are as defined in the claims, which are of use in the treatment of cancer, and related aspects. |
| priorityDate | 2015-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 367.